Sensorium Therapeutics
Surya is a consultant at Sensorium Therapeutics. She advises Sensorium and the R&D team predominantly about neurobiology and the integration of Sensorium’s Platform activities between the different departments. Surya is the Programs & Innovations Manager for Stephen Haggarty’s academic lab at MGH and a Senior Neuroscientist and Project Leader at MGH’s Center for the Neuroscience of Psychedelics. Her expertise is in CNS drug discovery, neuronal assay development, and image and data analysis pipeline development. Initially studying Biology (with an emphasis on botany) and Mathematics in Germany, Surya received a B.Sc. in Human Genetics at University College London and then a Ph.D. in Clinical Genetics at Erasmus MC/ University Rotterdam.
This person is not in any offices
Sensorium Therapeutics
Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world.